MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.mayocp.2022.09.005

Медицинская библиотека · Mayo Clinic proceedings · 2022

Characteristics, Treatment Patterns, and Clinical Outcomes After Heart Failure Hospitalizations During the COVID-19 Pandemic, March to October 2020.

Yousufuddin Mohammed, Yamani Mohamad H, Kashani Kianoush B, Zhu Ye, Wang Zhen, Seshadri Ashok, Blocker Katherine R, Peters Jessica L, Doss Jewell M, Karam Dhauna, Khandelwal Kanika, Sharma Umesh M, Dudenkov Daniel V, Mehmood Tahir, Pagali Sandeep R, Nanda Sanjeev, Abdalrhim Ahmed D, Cummings Nichole, Dugani Sagar B, Smerina Michael, Prokop Larry J, Keenan Lawrence R, Bhagra Sumit, Jahangir Arshad, Bauer Philippe R, Fonarow Gregg C, Murad Mohammad Hassan

Многоцентровое исследованиеСтатьяПоддержка NIH: внешняя программаПоддержка исследования: вне правительства СШАПеревод пока не подготовлен

Аннотация

OBJECTIVE

To compare clinical characteristics, treatment patterns, and 30-day all-cause readmission and mortality between patients hospitalized for heart failure (HF) before and during the coronavirus disease 2019 (COVID-19) pandemic.

PATIENTS AND

METHODS

The study was conducted at 16 hospitals across 3 geographically dispersed US states. The study included 6769 adults (mean age, 74 years; 56% [5033 of 8989] men) with cumulative 8989 HF hospitalizations: 2341 hospitalizations during the COVID-19 pandemic (March 1 through October 30, 2020) and 6648 in the pre-COVID-19 (October 1, 2018, through February 28, 2020) comparator group. We used Poisson regression, Kaplan-Meier estimates, multivariable logistic, and Cox regression analysis to determine whether prespecified study outcomes varied by time frames.

RESULTS

The adjusted 30-day readmission rate decreased from 13.1% (872 of 6648) in the pre-COVID-19 period to 10.0% (234 of 2341) in the COVID-19 pandemic period (relative risk reduction, 23%; hazard ratio, 0.77; 95% CI, 0.66 to 0.89). Conversely, all-cause mortality increased from 9.7% (645 of 6648) in the pre-COVID-19 period to 11.3% (264 of 2341) in the COVID-19 pandemic period (relative risk increase, 16%; number of admissions needed for one additional death, 62.5; hazard ratio, 1.19; 95% CI, 1.02 to 1.39). Despite significant differences in rates of index hospitalization, readmission, and mortality across the study time frames, the disease severity, HF subtypes, and treatment patterns remained unchanged (P>0.05).

CONCLUSION

The findings of this large tristate multicenter cohort study of HF hospitalizations suggest lower rates of index hospitalizations and 30-day readmissions but higher incidence of 30-day mortality with broadly similar use of HF medication, surgical interventions, and devices during the COVID-19 pandemic compared with the pre-COVID-19 time frame.

Для цитирования: Yousufuddin Mohammed, Yamani Mohamad H, Kashani Kianoush B, Zhu Ye, Wang Zhen, Seshadri Ashok, Blocker Katherine R, Peters Jessica L, Doss Jewell M, Karam Dhauna, Khandelwal Kanika, Sharma Umesh M, Dudenkov Daniel V, Mehmood Tahir, Pagali Sandeep R, Nanda Sanjeev, Abdalrhim Ahmed D, Cummings Nichole, Dugani Sagar B, Smerina Michael, Prokop Larry J, Keenan Lawrence R, Bhagra Sumit, Jahangir Arshad, Bauer Philippe R, Fonarow Gregg C, Murad Mohammad Hassan. Characteristics, Treatment Patterns, and Clinical Outcomes After Heart Failure Hospitalizations During the COVID-19 Pandemic, March to October 2020.. Mayo Clinic proceedings. 2022. DOI: 10.1016/j.mayocp.2022.09.005.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.